Maxim A.X. Tollenaere, Christina Mølck, Ian Henderson, Scott Pollack, Philip Addis, Helle Heibroch Petersen, & Hanne Norsgaard. (2023). Tralokinumab Effectively Disrupts the IL-13/IL-13Rα1/IL-4Rα Signaling Complex but Not the IL-13/IL-13Rα2 Complex. Elsevier.
Chicago Style (17th ed.) CitationMaxim A.X. Tollenaere, Christina Mølck, Ian Henderson, Scott Pollack, Philip Addis, Helle Heibroch Petersen, and Hanne Norsgaard. Tralokinumab Effectively Disrupts the IL-13/IL-13Rα1/IL-4Rα Signaling Complex but Not the IL-13/IL-13Rα2 Complex. Elsevier, 2023.
MLA (9th ed.) CitationMaxim A.X. Tollenaere, et al. Tralokinumab Effectively Disrupts the IL-13/IL-13Rα1/IL-4Rα Signaling Complex but Not the IL-13/IL-13Rα2 Complex. Elsevier, 2023.
Warning: These citations may not always be 100% accurate.